NO20055694L - Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav - Google Patents

Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav

Info

Publication number
NO20055694L
NO20055694L NO20055694A NO20055694A NO20055694L NO 20055694 L NO20055694 L NO 20055694L NO 20055694 A NO20055694 A NO 20055694A NO 20055694 A NO20055694 A NO 20055694A NO 20055694 L NO20055694 L NO 20055694L
Authority
NO
Norway
Prior art keywords
hydroxy
acetonitrile
preparation
pyran
tetrahydro
Prior art date
Application number
NO20055694A
Other languages
English (en)
Other versions
NO20055694D0 (no
Inventor
Wilhelmus Hubertus Jos Boesten
Daniel Mink
Michael Wolberg
Natascha Sereinig
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of NO20055694D0 publication Critical patent/NO20055694D0/no
Publication of NO20055694L publication Critical patent/NO20055694L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)

Abstract

Oppfmnelsen vedrører en fremgangsmåte for fremstilling av (4-hydroksy-6-okso-tefrahydro- pyran-2-yl)-acetonitril fra 6-X-substituert-metyl-4-hydroksy-tefrahydro-pyran-2-on, hvori X står for en forlatende gruppe, ved å reagere 6-Xsubstituert-metyl-4-hydroksy-tefrahydro-pyran-2-on med et cyanidion i vann og ved påfølgende senking av pHen til en pH mellom 0 og 5. (4-Hydroksy-6-okso- tefrahydro-pyran-2-yl)-acetonitril og andre forbindelser som kan oppnås fra (4-hydroksy-6-okso- tefrahydro-pyran-2-yl)-acetonitril kan egnet anvendes i fremstillingen av et farmasøytisk preparat, mer spesielt i fremstillingen av statiner, mer spesielt i fremstillingen av Atorvastatine eller et salt derav, for eksempel dets kalsiimisalt. Oppfirmelsen vedrører også (4-hydroksy-6-okso-tetrahydro-pyran-2-yl)- acetonitril og andre forbindelser som kan oppnås derfra.
NO20055694A 2003-05-02 2005-12-01 Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav NO20055694L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101227 2003-05-02
PCT/NL2004/000284 WO2004096788A1 (en) 2003-05-02 2004-04-28 Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof

Publications (2)

Publication Number Publication Date
NO20055694D0 NO20055694D0 (no) 2005-12-01
NO20055694L true NO20055694L (no) 2006-02-02

Family

ID=33395971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055694A NO20055694L (no) 2003-05-02 2005-12-01 Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav

Country Status (24)

Country Link
US (1) US7423162B2 (no)
EP (1) EP1620423B1 (no)
JP (1) JP2006525323A (no)
KR (1) KR20060011984A (no)
CN (2) CN1780826B (no)
AT (1) ATE386734T1 (no)
AU (1) AU2004234308A1 (no)
BR (1) BRPI0409866A (no)
CA (1) CA2524457A1 (no)
CO (1) CO5700715A2 (no)
CY (1) CY1113498T1 (no)
DE (1) DE602004011921T2 (no)
DK (1) DK1620423T3 (no)
EA (1) EA010100B1 (no)
ES (1) ES2300769T3 (no)
IL (1) IL171539A (no)
IS (1) IS8159A (no)
NO (1) NO20055694L (no)
NZ (1) NZ543294A (no)
PL (1) PL1620423T3 (no)
SI (1) SI1620423T1 (no)
UA (1) UA83662C2 (no)
WO (1) WO2004096788A1 (no)
ZA (1) ZA200508862B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012246A1 (en) 2003-07-25 2005-02-10 Avecia Pharmaceuticals Limited Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin
US7701550B2 (en) 2004-08-19 2010-04-20 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
DE102005022284A1 (de) * 2005-05-13 2006-11-23 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen
US8047545B2 (en) * 2007-11-07 2011-11-01 Douglas Press, Inc. Lottery-type game with rollover feature
CA2713009C (en) * 2008-01-23 2018-08-28 Lek Pharmaceuticals D.D. ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof
EP2614057B1 (en) * 2010-09-09 2015-10-21 DSM Sinochem Pharmaceuticals Netherlands B.V. Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
SI2616454T1 (sl) * 2010-09-16 2015-08-31 Dsm Sinochem Pharmaceuticals Netherlands B.V. Estri heksanojskih kislin, kot vmesne spojine za pripravo atorvastatina
CN105669637A (zh) * 2014-11-21 2016-06-15 南京博优康远生物医药科技有限公司 一种3,5,6-取代己酸酯衍生物的制备方法
CN112501223B (zh) * 2020-11-23 2022-08-12 江苏阿尔法药业股份有限公司 制备2-((2r,4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法
CN116102482A (zh) * 2022-08-17 2023-05-12 重庆普佑生物医药有限公司 一种阿托伐他汀钙的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003080A (en) 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
US5097045A (en) * 1989-02-01 1992-03-17 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
US7414119B2 (en) * 2002-09-20 2008-08-19 Verenium Corporation Aldolases, nucleic acids encoding them and methods for making and using them

Also Published As

Publication number Publication date
CN101775000A (zh) 2010-07-14
CO5700715A2 (es) 2006-11-30
NO20055694D0 (no) 2005-12-01
US20060258733A1 (en) 2006-11-16
PL1620423T3 (pl) 2008-07-31
US7423162B2 (en) 2008-09-09
CN101775000B (zh) 2014-09-24
DE602004011921D1 (de) 2008-04-03
BRPI0409866A (pt) 2006-05-16
EA010100B1 (ru) 2008-06-30
EA200501734A1 (ru) 2006-04-28
EP1620423B1 (en) 2008-02-20
CA2524457A1 (en) 2004-11-11
WO2004096788A1 (en) 2004-11-11
ZA200508862B (en) 2007-02-28
IL171539A (en) 2011-03-31
EP1620423A1 (en) 2006-02-01
DK1620423T3 (da) 2008-05-26
SI1620423T1 (sl) 2008-06-30
DE602004011921T2 (de) 2009-02-19
KR20060011984A (ko) 2006-02-06
IS8159A (is) 2005-11-30
JP2006525323A (ja) 2006-11-09
UA83662C2 (ru) 2008-08-11
AU2004234308A1 (en) 2004-11-11
ATE386734T1 (de) 2008-03-15
NZ543294A (en) 2008-05-30
ES2300769T3 (es) 2008-06-16
CY1113498T1 (el) 2016-06-22
CN1780826A (zh) 2006-05-31
CN1780826B (zh) 2010-05-26

Similar Documents

Publication Publication Date Title
NO20055694L (no) Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav
NO20100062L (no) Overflatereagert kalsiumkarbonat i kombinasjon med hydrofob adsorbent for vannbehandling
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
HRP20050641A2 (en) New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof
EA201070001A1 (ru) Водная композиция, содержащая соль, способ её получения и применения
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
WO2006012395A3 (en) Peptidase inhibitors
BR0308385A (pt) Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso
PL1751093T3 (pl) Podstawione pochodne kwasu cykloheksylooctowego
MX2009005863A (es) Procedimiento para la preparacion de compuestos heterociclicos sustituidos por fluorometilo.
NO20055750L (no) Nye kjemiske forbindelser
NO20050270L (no) Nye forbindelser, deres anvendelse og fremstilling
NO20060718L (no) Substituerte tiofoner og deres anvendelse
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
TW200635905A (en) Processes for producing 4-aminoquinazolines
TW200719889A (en) Amino acid derivatives
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
SE0200843D0 (sv) Chemical compounds
KR101632545B1 (ko) 황산 환원균의 선택적 제균방법, 상기 방법에 의해 황산 환원균의 증식을 억제하는 석고 조성물, 석고계 고화재 및 석고계 건재
TW200722419A (en) Chemical compounds
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
RU2006110716A (ru) Способ получения полиметилентетразолов
IL158530A0 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
TH79415A (th) กระบวนการสำหรับการเตรียมไพริมิดีนที่ถูกแทนที่
TW200616893A (en) Method for manufacturing aluminum salt solution, aluminum salt solution, aluminum salt, water purifying apparatus using the same, and articles manufactured by using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application